Fed. Circ. Says PTAB Didn't Explain Itself In NuVasive Review
The Federal Circuit on Wednesday reversed a Patent Trial and Appeal Board decision that claims in a NuVasive Inc. spinal surgery patent were invalid, finding the PTAB did not adequately explain...To view the full article, register now.
Already a subscriber? Click here to view full article